https://www.selleckchem.com/products/mm3122.html
No or other nanophthalmos-associated gene variants were detected in the 12 normal controls. An appropriate approach was adopted to investigate the genetics of PACG through nanophthalmos-associated genes. A genetic variant, , was identified in four out of 45 PACG patients, which might be a novel candidate gene for PACG. An appropriate approach was adopted to investigate the genetics of PACG through nanophthalmos-associated genes. A genetic variant, MYRF, was identified in four out of 45 PACG patients, which might be a novel candidate gene
Like
Comment
Share
